What the research found

A 2023 study tracked 25 adults with obesity through two months of structured intermittent energy restriction, combining a highly controlled calorie deficit phase with a semi-supervised phase. The team measured gut microbiome composition via stool analysis, blood metabolic markers, and brain activity using fMRI across regions implicated in appetite control, reward, emotion, and executive function.

Weight loss averaged 7.6 kg (~8% of starting weight), accompanied by improvements in blood pressure, fasting glucose, cholesterol levels, and liver enzyme activity. Simultaneously, the researchers observed a reshuffling of gut bacteria—increases in Faecalibacterium prausnitzii, Parabacteroides distasonis, and Bacteroides uniformis, alongside a drop in Escherichia coli. Brain imaging showed reduced activity in appetite and addiction-related regions.

The novel finding was a correlation between specific bacterial taxa and distinct brain regions. For example, lower E. coli and higher P. distasonis abundance mapped onto changes in areas controlling inhibition and attention. The data suggest that gut microbiome composition and brain activity change in concert during weight loss, though the study could not determine causation or direction of influence.

Why it matters for you

If you're tracking weight loss or body composition, this research reframes the process beyond simple caloric math. Your experience of hunger, cravings, and willpower—things you might think of as purely psychological—correlate with measurable shifts in your microbiome and brain activity. That means optimising for sustainable fat loss may require attention to microbial health, not just macros or meal timing.

The specific bacterial shifts identified (Faecalibacterium and Parabacteroides elevation) are recognised markers of metabolic health. If you're monitoring stool microbiome data (increasingly available via consumer testing), you could look for these compositional changes as confirmatory signals that your protocol is working at the systems level. The link to improved executive function regions also suggests that a successful dietary intervention might make adherence easier over time, not just through conscious effort.

The metabolic markers measured—lipids, fasting glucose, liver enzymes, blood pressure—are standard biomarkers many MyKine users already track. This study hints that improvements in these numbers may partly reflect a normalising of gut-brain communication, not just net energy balance.

Caveats

• Small, geographically homogeneous sample: 25 adults, all from China, average age 27. Results may not generalise across ages, genetic backgrounds, or healthcare contexts.
• Observational correlation, not causation: The study documents that microbiome and brain changes occur together during weight loss but cannot prove which drives which, or whether a third factor (e.g. dietary composition, physical activity, sleep) influences both.
• No control group: No parallel group eating normally for comparison, limiting confidence that the observed microbiome shifts are specific to this intervention rather than weight loss itself.
• Short intervention window: 62 days total; durability of changes and long-term weight maintenance are unknown.
• Early follow-up literature: The source notes that post-2023 systematic reviews on fasting and microbiota remain mixed and complex; consensus is incomplete.